1.
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, mult...
by Sibbing, Dirk
The Lancet (British edition), 2017, Vol.390 (10104), p.1747-1757
2.
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled tr...
by Dewilde, Willem JM, Dr
The Lancet (British edition), 2013, Vol.381 (9872), p.1107-1115
3.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre,...
by Ohman, E Magnus, Dr Prof
The Lancet (British edition), 2017, Vol.389 (10081), p.1799-1808
4.
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURREN...
by Mehta, Shamir R, Dr
The Lancet (British edition), 2010, Vol.376 (9748), p.1233-1243
5.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data
by Li, Jing, PhD
The Lancet (British edition), 2015, Vol.385 (9966), p.441-451
6.
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised...
by Bøtker, Hans Erik, Prof
The Lancet (British edition), 2010, Vol.375 (9716), p.727-734
7.
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subje...
by Gibson, C. Michael, MS, MD
The American heart journal, 2014, Vol.169 (4), p.472-478.e5
8.
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline charact...
by James, Stefan
The American heart journal, 2009, Vol.157 (4), p.599-605
9.
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE...
by Connolly, S
The Lancet (British edition), 2006, Vol.367 (9526), p.1903-1912
10.
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary interv...
by Wiviott, Stephen D, Dr
The Lancet (British edition), 2008, Vol.371 (9621), p.1353-1363
11.
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
by Brandt, John T., MD
The American heart journal, 2007, Vol.153 (1), p.66.e9-66.e16
12.
Meta-Analysis of Randomized Controlled Trials and Adjusted Observational Results of Use of Clopidogrel, Aspirin, and Oral Anticoagulants in Patients Undergoing Percutaneous Coronar...
by D'Ascenzo, Fabrizio, MD
The American journal of cardiology, 2015, Vol.115 (9), p.1185-1193
13.
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
by Velders, Matthijs A
Heart (British Cardiac Society), 2016, Vol.102 (8), p.617-625
14.
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo...
by Diener, Hans-Christoph
The Lancet (British edition), 2004, Vol.364 (9431), p.331-337
15.
Dual Antiplatelet Therapy Versus Aspirin Alone in Patients Undergoing Transcatheter Aortic Valve Implantation
by Ussia, Gian Paolo, MD
The American journal of cardiology, 2011, Vol.108 (12), p.1772-1776
16.
Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non–ST-Elevation Acute Coronary Syndrome
by Bavishi, Chirag, MD, MPH
The American journal of cardiology, 2015, Vol.116 (5), p.809-817
17.
18.
Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
by Aradi, Dániel, MD, PhD
The American heart journal, 2010, Vol.160 (3), p.543-551
19.
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
by Nijenhuis, Vincent Johan, MD
The American heart journal, 2015, Vol.173, p.77-85
20.
Clinical evidence for oral antiplatelet therapy in acute coronary syndromes
by Wiviott, Stephen D, MD
The Lancet (British edition), 2015, Vol.386 (9990), p.292-302
